BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 19164811)

  • 1. Associations of pentraxin 3 with cardiovascular disease and all-cause death: the Cardiovascular Health Study.
    Jenny NS; Arnold AM; Kuller LH; Tracy RP; Psaty BM
    Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):594-9. PubMed ID: 19164811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of pentraxin 3 with cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis.
    Jenny NS; Blumenthal RS; Kronmal RA; Rotter JI; Siscovick DS; Psaty BM
    J Thromb Haemost; 2014 Jun; 12(6):999-1005. PubMed ID: 24628740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum amyloid P and cardiovascular disease in older men and women: results from the Cardiovascular Health Study.
    Jenny NS; Arnold AM; Kuller LH; Tracy RP; Psaty BM
    Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):352-8. PubMed ID: 17138933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated levels of systemic pentraxin 3 are associated with thin-cap fibroatheroma in coronary culprit lesions: assessment by optical coherence tomography and intravascular ultrasound.
    Koga S; Ikeda S; Yoshida T; Nakata T; Takeno M; Masuda N; Koide Y; Kawano H; Maemura K
    JACC Cardiovasc Interv; 2013 Sep; 6(9):945-54. PubMed ID: 23954061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex Differences in the Association Between Pentraxin 3 and Cognitive Decline: The Cardiovascular Health Study.
    Miller LM; Jenny NS; Rawlings AM; Arnold AM; Fitzpatrick AL; Lopez OL; Odden MC
    J Gerontol A Biol Sci Med Sci; 2020 Jul; 75(8):1523-1529. PubMed ID: 31808814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: data from the Heart and Soul Study.
    Dubin R; Li Y; Ix JH; Shlipak MG; Whooley M; Peralta CA
    Am Heart J; 2012 Feb; 163(2):274-9. PubMed ID: 22305847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure.
    Suzuki S; Takeishi Y; Niizeki T; Koyama Y; Kitahara T; Sasaki T; Sagara M; Kubota I
    Am Heart J; 2008 Jan; 155(1):75-81. PubMed ID: 18082493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma pentraxin 3 is associated with cardiovascular disease in hemodialysis patients.
    Xu Y; Ding X; Zou J; Liu Z; Jiang S; Xu S; Shen B; Chen Y; Shan Y; Cao X
    Ren Fail; 2011; 33(10):998-1004. PubMed ID: 22013933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pentraxin 3 as a new indicator of cardiovascular‑related death in patients with advanced chronic kidney disease.
    Krzanowski M; Krzanowska K; Gajda M; Dumnicka P; Dziewierz A; Woziwodzka K; Litwin JA; Sułowicz W
    Pol Arch Intern Med; 2017 Feb; 127(3):170-177. PubMed ID: 28377558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of carotid artery intima-media thickness, plaques, and C-reactive protein with future cardiovascular disease and all-cause mortality: the Cardiovascular Health Study.
    Cao JJ; Arnold AM; Manolio TA; Polak JF; Psaty BM; Hirsch CH; Kuller LH; Cushman M
    Circulation; 2007 Jul; 116(1):32-8. PubMed ID: 17576871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pentraxin 3 (PTX3) is associated with cardiovascular risk factors: the Health 2000 Survey.
    Jylhävä J; Haarala A; Kähönen M; Lehtimäki T; Jula A; Moilanen L; Kesäniemi YA; Nieminen MS; Hurme M
    Clin Exp Immunol; 2011 May; 164(2):211-7. PubMed ID: 21391986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated plasma pentraxin 3: a potential cardiovascular risk factor?
    Liu Q; Tu T; Bai Z; Liu Z; Zhou S
    Med Hypotheses; 2011 Dec; 77(6):1068-70. PubMed ID: 21944885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long Pentraxin 3 as a Predictive Marker of Mortality in Severe Septic Patients Who Received Successful Early Goal-Directed Therapy.
    Kim SB; Lee KH; Lee JU; Ann HW; Ahn JY; Jeon YD; Kim JH; Ku NS; Han SH; Choi JY; Song YG; Kim JM
    Yonsei Med J; 2017 Mar; 58(2):370-379. PubMed ID: 28120568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac rehabilitation decreases plasma pentraxin 3 in patients with cardiovascular diseases.
    Fukuda T; Kurano M; Iida H; Takano H; Tanaka T; Yamamoto Y; Ikeda K; Nagasaki M; Monzen K; Uno K; Kato M; Shiga T; Maemura K; Masuda N; Yamashita H; Hirata Y; Nagai R; Nakajima T
    Eur J Prev Cardiol; 2012 Dec; 19(6):1393-400. PubMed ID: 21914683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction.
    Latini R; Maggioni AP; Peri G; Gonzini L; Lucci D; Mocarelli P; Vago L; Pasqualini F; Signorini S; Soldateschi D; Tarli L; Schweiger C; Fresco C; Cecere R; Tognoni G; Mantovani A;
    Circulation; 2004 Oct; 110(16):2349-54. PubMed ID: 15477419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between IL-10 levels and cardiovascular events in patients with CKD.
    Yilmaz MI; Solak Y; Saglam M; Cayci T; Acikel C; Unal HU; Eyileten T; Oguz Y; Sari S; Carrero JJ; Stenvinkel P; Covic A; Kanbay M
    Clin J Am Soc Nephrol; 2014 Jul; 9(7):1207-16. PubMed ID: 24789549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating levels of pentraxin-3 (PTX3) in patients with liver cirrhosis.
    Narciso-Schiavon JL; Pereira JG; Silva TE; Bansho ETO; Morato EF; Pinheiro JT; Muraro-Wildner L; Bazzo ML; Dantas-Corrêa EB; Schiavon LL
    Ann Hepatol; 2017; 16(5):780-787. PubMed ID: 28809733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pentraxin 3: a novel and independent prognostic marker in ischemic stroke.
    Ryu WS; Kim CK; Kim BJ; Kim C; Lee SH; Yoon BW
    Atherosclerosis; 2012 Feb; 220(2):581-6. PubMed ID: 22178425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple inflammatory biomarkers in relation to cardiovascular events and mortality in the community.
    Schnabel RB; Yin X; Larson MG; Yamamoto JF; Fontes JD; Kathiresan S; Rong J; Levy D; Keaney JF; Wang TJ; Murabito JM; Vasan RS; Benjamin EJ
    Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1728-33. PubMed ID: 23640499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-reactive protein, insulin resistance and risk of cardiovascular disease: a population-based study.
    Jeppesen J; Hansen TW; Olsen MH; Rasmussen S; Ibsen H; Torp-Pedersen C; Hildebrandt PR; Madsbad S
    Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):594-8. PubMed ID: 18753952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.